Okcheonwon

Manufacturer
Chunwoo Pharmaceutical Co., Ltd.
Effective date
2022-01-31
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 02:15:41

Label at a glance#

ProductOkcheonwon
Active ingredientLICORICE, TRICHOSANTHES KIRILOWII ROOT, PUERARIA MONTANA VAR. LOBATA ROOT, LIRIOPE MUSCARI ROOT, PRUNUS MUME FRUIT, ASTRAGALUS MONGHOLICUS ROOT, ASIAN GINSENG, OPHIOPOGON JAPONICUS ROOT
Label structure8 sections

Indications and uses

Thirst from diabetes

Dosage and administration

For adults, take 1 case (15 pills)l a day, before or between meals

Label contents#

Full prescribing information#

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Trichosanthes Kirilowii Root }

Pueraria Lobata Root }

Liriope Muscari Root }

Ophiopogon japonicus Root } ------------------------------------------------ Diabetes

Prunus Mume Fruit }

Astragalus Mongholicus Root }

Asian Ginseng }

Licorice }

Purpose

OTC - PURPOSE SECTION

Diabetes

Directions

DOSAGE & ADMINISTRATION SECTION

For adults, take 1 case (15 pills)l a day, before or between meals

Inactive ingredients

INACTIVE INGREDIENT SECTION

Corn Starch, Animal originated ingredients: Lactose Hydrate/Cow Milk

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Warnings

WARNINGS SECTION

Warnings

Do not use if you have

  • galactose intolerance
  • lapp lactase deficiency
  • glucose-galactose malabsorption (this medicine contains lactose)

Ask a doctor before use if you are

  • a hypertensive
  • a heart or kidney patient
  • an edema patient
  • a patient who is being treated by a doctor or taking other medications.
  • an elderly person (in general, elderly people should take with care, such as reducing their dosage, as their physiological function has deteriorated.)
  • a child (the safety of children's use is not established. (Less experience in use))

Stop use and ask a doctor, pharmacist or health professionals and bring this if you have following symptoms after use:

  • Pseudohyperaldosteronism: Reduced urine volume, swollen face, swollen hands and feet, heavy eyelids, firm hands, increased blood pressure, headache, and etc. (Mediciness with a maximum daily dose of 1g or more may develop hypoglycemia, blood pressure rise, low sodium body fluid, edema, weight gain, and etc. caused by pseydohyperaldosteronism if taken continuously for a long time. Therefore, make sufficient observations (measurement of serum potassium levels) and stop taking if there is any abnormality.)
  • Myopathy: Myopathy (muscle disease) may occur as a result of hypokalemia, so take sufficient observation and stop taking if you find any abnormalities such as feeling helplessness, limb cramps, paralysis, and etc.
  • Skin trouble: a rash, itch, bloodshot, and etc.
  • Digestive system disorder: anorexia, stomach discomfort, nausea, vomiting, and etc.
  • Liver disorder: jaundice, fatigue, and etc.
  • Interstitial lung disease: difficult to breathe, fever, and etc. accompanied by a cough.
  • Urinary system disorder: dysuria
  • The autonomic system disorder: insomnia, excessive sweating, fast pulse, frequent urination, palpitations, feeling helplessness, excitement, and etc.
  • If there is no improvement in symptoms after taking it for one month

Other Warnings

  • do not take more than directed
  • when taken with potassium-containing agents, licorice-containing agents, glycirizinic acid or other related agents, loop diuretics (furosemide, ethacrynic acid), or thiazide diuretics (trichlormethiazide) and myopathy, it is likely to appear due to gastric aldosterone (pseudohyperaldosteronism) or hypokalemia
  • if taken with other herbal medicines, be careful of overlapping of the crude medicines.
  • in principle, you should not to take it continuously for a long time, but if it is necessary, consult with a doctor, herb doctor, dentist, pharmacist, or other health care professionals.
  • it is easy to experience symptoms such as insomnia, hyperhidrosis, rapid pulse, frequent urination, palpitations, general fatigue, and mental excitement when use with Ephedra Sinica Stem or ephedrine-containing agents, MAO inhibitors, thyroid agents (thyroxine, liothyronine), catecholamine (epinephrine, isoprenaline) and xanthine agents (theophylline, diprophylline) so take it carefully, such as reducing the dose.

Uses

INDICATIONS & USAGE SECTION

Thirst from diabetes

Okcheonwon

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

okcheonwonokcheonwon

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
72850-0008-32024-01-30C16284748780-11030e365-0a89-111a-e063-dadaa90a10e2Okcheonwon

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72850-0008-1Okcheonwon15 g in 1 BLISTER PACKPILL152
72850-0008-2Okcheonwon30 in 1 CASEPILL302
72850-0008-3Okcheonwon1 in 1 BOXPILL12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72850-0008OKCHEONWON (TRICHOSANTHES KIRILOWII ROOT, PUERARIA LOBATA ROOT, LIRIOPE MUSCARI ROOT, OPHIOPOGON JAPONICUS ROOT, PRUNUS MUME FRUIT, ASTRAGALUS MONGHOLICUS ROOT, ASIAN GINSENG, LICORICE) PILL [CHUNWOO PHARMACEUTICAL CO., LTD.]2Legacy NDC, 3 package rows20220201_d57fe444-5342-8a3f-e053-2995a90a6b25.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72850-000872850-0008-1, 72850-0008-2, 72850-0008-3

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
d6e95bba-b90b-e9ac-e053-2995a90a44a6d57fe444-5342-8a3f-e053-2995a90a6b252022-01-31WarningsExact identifier
spl id: d6e95bba-b90b-e9ac-e053-2995a90a44a6
spl set id: d57fe444-5342-8a3f-e053-2995a90a6b25

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.